Digital asset gains drive ENDRA to Q2 profit; merger closing expected in Q4
NDRA sits 52% above its 52-week low of $2.96.
Summary
ENDRA Life Sciences posted a surprise Q2 profit of $160,000, aided by digital asset gains, and said its merger with Noble Africa is expected to close in Q4 2026.
Key Events · Earnings and Guidance · NDRA
-
Q2 Net Income of $160K
Net income reached $160,000 in Q2 2026, a sharp turnaround from the $1.2M loss in Q2 2025, driven by $1.6M in other income from digital asset gains.
-
Cash Position
As of June 30, 2026, the company held $1.7M in cash, $3.8M in restricted cash, and $1.9M in digital assets.
-
Merger Timeline
The Noble Africa merger is expected to close in Q4 2026, subject to stockholder and regulatory approvals.
-
Operating Expense Reductions
R&D expenses fell 39% and sales and marketing expenses dropped 92% compared to Q2 2025, reflecting disciplined cost management.
Analysis · NDRA · Industrial Applications And Services
A $1.6M gain on digital assets helped swing ENDRA to a $160,000 net profit in Q2 2026, reversing a $1.2M loss from the prior year. The company also reaffirmed that the Noble Africa merger remains on track to close in Q4 2026, pending approvals. While the profit is modest and largely non-operational, the update offers clarity on cash runway and merger timing for a company that was recently facing delisting.
At the time of this filing, NDRA was trading at $4.49 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.7M. The 52-week trading range was $2.96 to $9.85. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.